Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
August-2018 Volume 16 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2018 Volume 16 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Antitumor effects of carbon nanotube‑drug complex against human breast cancer cells

  • Authors:
    • Shiping Yu
    • Yi Zhang
    • Lin Chen
    • Qiang Li
    • Jinglei Du
    • Yuduan Gao
    • Li Zhang
    • Yongzhen Yang
  • View Affiliations / Copyright

    Affiliations: Department of Interventional Therapy, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China, Department of Radiology, Peace Hospital of Changzhi Medical University, Changzhi, Shanxi 046000, P.R. China, Key Laboratory of Interface Science and Engineering in Advanced Materials, Ministry of Education, Taiyuan University of Technology, Taiyuan, Shanxi 030024, P.R. China, Department of Medical Imageology, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China, Department of Ophthalmology, Shanxi Dayi Hospital, Taiyuan, Shanxi 030032, P.R. China, Department of Urinary Surgery, Shanxi Dayi Hospital, Taiyuan, Shanxi 030032, P.R. China
    Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
  • Pages: 1103-1110
    |
    Published online on: June 20, 2018
       https://doi.org/10.3892/etm.2018.6334
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

To improve the bio‑solubility and sustained‑release properties of a carbon nanotube (CNT)‑drug complex, the present study used a hydrophilic polymer, polyethylene glycol (PEG), and β‑estradiol (E2), which targets the estrogen receptor in human breast cancer cells (HBCCs), to modify CNTs carrying lobaplatin (LBP) to form E2‑PEG‑CNT‑LBP. The in vitro inhibitory effects against HBCCs and the in vivo pharmacological effect of the complex on heart, liver and kidney tissues were also evaluated. The results indicated that the inhibitory effects of this complex against HBCCs reached 80.44% within 72 h. A blood biochemical test of normal mice indicated that this complex reduced platelet counts, while aspartate aminotransferase levels were increased compared with those in the control group. Histopathological analysis revealed no obvious adverse effects on the heart, liver and kidneys. The in vivo results indicated that the novel E2‑PEG‑CNT‑LBP complex had no obvious toxic effects while exhibiting sustained‑release properties. The clearance of E2‑PEG‑CNT‑LBP by non‑specific uptake systems was delayed and its clearance was increased compared with LBP alone.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Grantzau T and Overgaard J: Risk of second non-breast cancer after radiotherapy for breast cancer: A systematic review and meta-analysis of 762,468 patients. Radiother Oncol. 114:56–65. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Bartelink H, Maingon P, Poortmans P, Weltens C, Fourquet A, Jager J, Schinagl D, Oei B, Rodenhuis C, Horiot JC, et al: Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. Lancet Oncol. 16:47–56. 2015. View Article : Google Scholar : PubMed/NCBI

3 

Giordano SH: Breast cancer chemotherapy cost variation substantial in the US. Pharmacoeconomics Outcomes News. 764:9. 2016. View Article : Google Scholar

4 

Bhatt S, Valamanesh F, Pulpytel J, Lo Dico R, Baiyukha A, Al-Dybiat I, Pocard M, Arefi-Khonsari F and Mirshahi M: Radio-frequency plasma polymerized biodegradable carrier for in vivo release of cis-platinum. Oncotarget. 7:58121–58132. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Guan X, Ma F, Fan Y, Zhu W, Hong R and Xu B: Platinum-based chemotherapy in triple-negative breast cancer: A systematic review and meta-analysis of randomized-controlled trials. Anticancer Drugs. 26:894–901. 2015. View Article : Google Scholar : PubMed/NCBI

6 

Laiva AL, Venugopal JR, Karuppuswamy P, Navaneethan B, Gora A and Ramakrishna S: Controlled release of titanocene into the hybrid nanofibrous scaffolds to prevent the proliferation of breast cancer cells. Int J Pharm. 483:115–123. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Beck-Broichsitter M, Merkel OM and Kissel T: Controlled pulmonary drug and gene delivery using polymeric nano-carriers. J Control Release. 161:214–224. 2012. View Article : Google Scholar : PubMed/NCBI

8 

Kim JY, Choi WI, Kim YH and Tae G: Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier. Biomaterials. 34:1170–1178. 2013. View Article : Google Scholar : PubMed/NCBI

9 

Dineshkumar B, Krishnakumar K, Bhatt AR, Paul D, Cherian J, John A and Suresh S: Single-walled and multi-walled carbon nanotubes based drug delivery system: Cancer therapy: A review. Indian J Cancer. 52:262–274. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Al Faraj A, Shaik AP and Shaik AS: Magnetic single-walled carbon nanotubes as efficient drug delivery nanocarriers in breast cancer murine model: Noninvasive monitoring using diffusion-weighted magnetic resonance imaging as sensitive imaging biomarker. Int J Nanomedicine. 10:157–168. 2014. View Article : Google Scholar : PubMed/NCBI

11 

Liu J, Wang C, Wang X, Wang X, Cheng L, Li Y and Liu Z: Mesoporous silica coated single-walled carbon nanotubes as a multifunctional light-responsive platform for cancer combination therapy. Adv Funct Mater. 25:384–392. 2015. View Article : Google Scholar

12 

Zhang W, He J, Liu Z, Ni P and Zhu X: Biocompatible and pH-responsive triblock copolymer mPEG-b-PCL-b-PDMAEMA: Synthesis, self-assembly, and application. J Polymer Sci Part A Polymer Chem. 48:1079–1091. 2010. View Article : Google Scholar

13 

Das M, Bandyopadhyay D, Singh R, Harde H, Kumar S and Jain SL: Orthogonal bio-functionalization of magnetic nano-particles via ‘clickable’ poly (ethylene glycol) silanes: A ‘universal ligand’ strategy to design stealth and target-specific nano-carriers. J Mater Chem. 22:24652–24667. 2012. View Article : Google Scholar

14 

Moghimi SM, Hunter AC and Murray JC: Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol Rev. 53:283–318. 2001.PubMed/NCBI

15 

Schiff R, Massarweh S, Shou J and Osborne CK: Breast cancer endocrine resistance: How growth factor signaling and estrogen receptor coregulators modulate response. Clin Cancer Res. 9:447S–454S. 2003.PubMed/NCBI

16 

Kurebayashi J, Otsuki T, Kunisue H, Tanaka K, Yamamoto S and Sonoo H: Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer. Clin Cancer Res. 6:512–518. 2000.PubMed/NCBI

17 

Horwitz KB and McGuire WL: Estrogen control of progesterone receptor in human breast cancer: Correlation with nuclear processing of estrogen receptor. J Biol Chem. 253:2223–2228. 1978.PubMed/NCBI

18 

Rai S, Paliwal R, Vaidya B, Gupta PN, Mahor S, Khatri K, Goyal AK, Rawat A and Vyas SP: Estrogen(s) and analogs as a non-immunogenic endogenous ligand in targeted drug/DNA delivery. Curr Med Chem. 14:2095–2109. 2007. View Article : Google Scholar : PubMed/NCBI

19 

Keely NO and Meegan MJ: Targeting tumors using estrogen receptor ligand conjugates. Curr Cancer Drug Targets. 9:370–380. 2009. View Article : Google Scholar : PubMed/NCBI

20 

Dao KL and Hanson RN: Targeting the estrogen receptor using steroid-therapeutic drug conjugates (hybrids). Bioconjug Chem. 23:2139–2158. 2012. View Article : Google Scholar : PubMed/NCBI

21 

Datir SR, Das M, Singh RP and Jain S: Hyaluronate tethered, ‘smart’ multiwalled carbon nanotubes for tumor-targeted delivery of doxorubicin. Bioconjug Chem. 23:2201–2213. 2012. View Article : Google Scholar : PubMed/NCBI

22 

Yu SP, Su XD, Du JL, Wang JL, Gao YD, Zhang L, Chen L, Yang YZ and Liu XG: The cytotoxicity of water soluble carbon nanotubes on human embryonic kidney and liver cancer cells. New Carbon Materials. 33:35–46. 2018. View Article : Google Scholar

23 

Carlson JC, Stefan MI, Parnis JM and Metcalfe CD: Direct UV photolysis of selected pharmaceuticals, personal care products and endocrine disruptors in aqueous solution. Water Res. 84:350–361. 2015. View Article : Google Scholar : PubMed/NCBI

24 

Salvador-Morales C, Townsend P, Flahaut E, Vénien-Bryand C, Vlandase A, Greena MLH and Sim RB: Binding of pulmonary surfactant proteins to carbon nanotubes; potential for damage to lung immune defense mechanisms. Carbon. 45:607–617. 2007. View Article : Google Scholar

25 

Wang DP, Li SR, Zhang M, Li ST, Zhang YP, Geng ZX and Li RF: Determination of Hematological and Biochemical Parameters in Three Stocks of Mice. Shiyandongwu Kexue Yu Guanli. 17:24–28. 2000.(In Chinese).

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Yu S, Zhang Y, Chen L, Li Q, Du J, Gao Y, Zhang L and Yang Y: Antitumor effects of carbon nanotube‑drug complex against human breast cancer cells. Exp Ther Med 16: 1103-1110, 2018.
APA
Yu, S., Zhang, Y., Chen, L., Li, Q., Du, J., Gao, Y. ... Yang, Y. (2018). Antitumor effects of carbon nanotube‑drug complex against human breast cancer cells. Experimental and Therapeutic Medicine, 16, 1103-1110. https://doi.org/10.3892/etm.2018.6334
MLA
Yu, S., Zhang, Y., Chen, L., Li, Q., Du, J., Gao, Y., Zhang, L., Yang, Y."Antitumor effects of carbon nanotube‑drug complex against human breast cancer cells". Experimental and Therapeutic Medicine 16.2 (2018): 1103-1110.
Chicago
Yu, S., Zhang, Y., Chen, L., Li, Q., Du, J., Gao, Y., Zhang, L., Yang, Y."Antitumor effects of carbon nanotube‑drug complex against human breast cancer cells". Experimental and Therapeutic Medicine 16, no. 2 (2018): 1103-1110. https://doi.org/10.3892/etm.2018.6334
Copy and paste a formatted citation
x
Spandidos Publications style
Yu S, Zhang Y, Chen L, Li Q, Du J, Gao Y, Zhang L and Yang Y: Antitumor effects of carbon nanotube‑drug complex against human breast cancer cells. Exp Ther Med 16: 1103-1110, 2018.
APA
Yu, S., Zhang, Y., Chen, L., Li, Q., Du, J., Gao, Y. ... Yang, Y. (2018). Antitumor effects of carbon nanotube‑drug complex against human breast cancer cells. Experimental and Therapeutic Medicine, 16, 1103-1110. https://doi.org/10.3892/etm.2018.6334
MLA
Yu, S., Zhang, Y., Chen, L., Li, Q., Du, J., Gao, Y., Zhang, L., Yang, Y."Antitumor effects of carbon nanotube‑drug complex against human breast cancer cells". Experimental and Therapeutic Medicine 16.2 (2018): 1103-1110.
Chicago
Yu, S., Zhang, Y., Chen, L., Li, Q., Du, J., Gao, Y., Zhang, L., Yang, Y."Antitumor effects of carbon nanotube‑drug complex against human breast cancer cells". Experimental and Therapeutic Medicine 16, no. 2 (2018): 1103-1110. https://doi.org/10.3892/etm.2018.6334
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team